DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…
Automation and AI emerge as critical differentiators for logistics services providers facing global instability, tariff volatility and cost pressures LONDON…
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing across challenging pharmaceutical and nutraceutical applications - BASEL,…
Peer-reviewed (in-press) study finds serum-based antibody tests align, but milk results vary—calling for improved milk-specific diagnostics to strengthen herd surveillance…
NEW DELHI, Oct. 29, 2025 /PRNewswire/ -- BML Munjal University (BMU), a Hero Group initiative, will host the 6th edition…
66% of responding senior leaders say AI has already driven significant productivity improvements across their organization 41% of respondents anticipate…
Vertex Pulmonary Embolectomy System with Transforming Fixation (TFX) Technology Demonstrates Excellent Safety, Performance and Cardiac RecoveryMENLO PARK, Calif.--(BUSINESS WIRE)--#TFX--Jupiter Endovascular,…
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible…